Teachers Retirement System of The State of Kentucky reduced its stake in Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 13.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,217 shares of the company’s stock after selling 17,430 shares during the period. Teachers Retirement System of The State of Kentucky owned approximately 0.06% of Tempus AI worth $8,863,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. V Square Quantitative Management LLC acquired a new stake in Tempus AI in the 3rd quarter valued at $27,000. EMC Capital Management bought a new stake in Tempus AI in the second quarter valued at $29,000. Ulland Investment Advisors LLC bought a new stake in Tempus AI in the third quarter valued at $41,000. Heritage Family Offices LLP acquired a new position in Tempus AI during the third quarter worth $45,000. Finally, CoreCap Advisors LLC raised its stake in Tempus AI by 293.4% during the second quarter. CoreCap Advisors LLC now owns 1,019 shares of the company’s stock worth $59,000 after acquiring an additional 760 shares in the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Tempus AI news, CAO Ryan M. Bartolucci sold 7,062 shares of the stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $75.00, for a total transaction of $529,650.00. Following the sale, the chief accounting officer owned 60,804 shares of the company’s stock, valued at $4,560,300. This represents a 10.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Andrew Polovin sold 2,951 shares of the stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $75.00, for a total transaction of $221,325.00. Following the sale, the executive vice president directly owned 135,189 shares in the company, valued at approximately $10,139,175. This represents a 2.14% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 978,449 shares of company stock valued at $72,226,961 over the last three months. Company insiders own 24.26% of the company’s stock.
Analysts Set New Price Targets
TEM has been the topic of several recent analyst reports. Raymond James Financial set a $80.00 target price on shares of Tempus AI in a research note on Wednesday, September 2nd. Needham & Company LLC increased their target price on shares of Tempus AI from $75.00 to $89.00 and gave the stock a “buy” rating in a research report on Monday, November 2nd. Stifel Nicolaus cut their price target on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating for the company in a report on Monday, August 3rd. The Goldman Sachs Group assumed coverage on shares of Tempus AI in a research report on Monday, September 21st. They issued a “neutral” rating and a $75.00 price target on the stock. Finally, Robert W. Baird boosted their price target on shares of Tempus AI from $85.00 to $92.00 and gave the company an “outperform” rating in a research report on Tuesday, November 3rd. Eleven analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Tempus AI currently has an average rating of “Hold” and an average target price of $79.37.
Check Out Our Latest Stock Report on Tempus AI
Tempus AI Trading Down 2.1%
Shares of TEM opened at $63.43 on Wednesday. The stock has a fifty day moving average price of $72.82 and a two-hundred day moving average price of $57.54. The company has a debt-to-equity ratio of 2.70, a quick ratio of 2.48 and a current ratio of 2.61. Tempus AI, Inc. has a 52-week low of $40.77 and a 52-week high of $89.09. The company has a market cap of $11.57 billion, a price-to-earnings ratio of -59.84 and a beta of 3.61.
Tempus AI (NASDAQ:TEM – Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.16. The company had revenue of $411.54 million for the quarter, compared to analyst estimates of $409.39 million. Tempus AI had a negative return on equity of 47.00% and a negative net margin of 12.54%. The business’s revenue was up 23.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.46) earnings per share. Analysts predict that Tempus AI, Inc. will post -1.20 EPS for the current fiscal year.
Tempus AI Company Profile
Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research. The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.
Recommended Stories
- Five stocks we like better than Tempus AI
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
